Troglitazone and vascular reactivity: Role of glucose and calcium

Metabolism: Clinical and Experimental

Volumn 48, Issue 1, 1999, Pages 125-130

  Ali, Syed S ^a   Igwe, Robert C ^a   Walsh, Mary F ^a   Sowers, James R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUCOSE; TROGLITAZONE;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DRUG EFFECT; GLUCOSE UTILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION; VASOMOTOR REFLEX;

EID: 0032951769     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90021-5     Document Type: Article

References (36)

1. Baron AD, Brechtel-Hook G, Johnson A, et al: Skeletal muscle blood flow: A possible link between insulin resistance and blood pressure. Hypertension 21:129-135, 1993
2. Hall JE, Brands MW, Dixon WN, et al: Obesity-induced hypertension: Renal function and systemic hemodynamics. Hypertension 22:292-299, 1993
3. Johnstone MR, Craeger SJ, Scales KM, et al: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510-2516, 1993
4. Kahn A, Seidel CL, Allen JC, et al: Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 22:735-742, 1993
5. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathetic adrenal system. N Engl J Med 334:374-381, 1996
6. Sowers JR: Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 29:691-699, 1997
7. Sowers JR, Epstein M: Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: An update. Hypertension 26:869-879, 1995
8. Sowers JR, Sowers PS, Peuler JD: Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 123:647-652, 1994
9. Standley PR, Ram JL, Sowers JR: Insulin attenuation of vascular smooth muscle calcium responses in Zucker lean and obese rats. Endocrinology 133:1693-1699, 1993
10. Ghazzi MN, Perez JE, Antonucci TK, et al: Cardiac and glycemic benefits of troglitazone treatment in NIDDM. Diabetes 46:433-439, 1997
11. Ogihara T, Rakugi H, Ikegami H, et al: Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 8:316-320, 1995
12. 2+ currents and not endothelial nitric oxide production. Diabetes 46:659-664, 1997
13. Dominguez LJ, Davidoff AJ, Srinivas PR, et al: Effects of metformin on tyrosine kinase activity, glucose transport, and intracellu-lar calcium in rat vascular smooth muscle. Endocrinology 137:113-121, 1996
14. Kahn AM, Song T: Effects of insulin on vascular smooth muscle contraction, in Sowers JR (ed): Contemporary Endocrinology: Endocrinology of the Vasculature. Totowa, NJ, Humana, 1996, pp 215-223
15. Saito F, Hori MT, Fittingott M, et al: Insulin attenuates agonistmediated calcium mobilization in cultured rat vascular smooth muscle cells. J Clin Invest 92:1161-1168, 1993
16. Standley PR, Zhang F, Ram JL, et al: Insulin attenuates vasopressin-induced calcium transient and voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest 88:1230-1236, 1991
17. Pershadsingh HA, Szollosi J, Benson S, et al: Effects of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension 21:1020-1023, 1993
18. Zhang F, Sowers JR, Ram JL, et al: Effects of pioglitazone on L-type calcium channels in vascular smooth muscle. Hypertension 24:170-175, 1994
19. Baron AD, Steinberg HO: Vascular actions of insulin in health and disease, in Sowers JR (ed): Contemporary Endocrinology: Endocrinology of the Vasculature. Totowa, NJ, Humana, 1996, pp 95-107
20. Scherrer U, Randin D, Vollenweider P, et al: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515, 1994
21. Steinberg HO, Brechtel G, Johnson A, et al: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: A novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994
22. Walsh MF, Barazi M, Pete G, et al: Insulin-like growth factor 1 diminishes in vivo and in vitro vascular contractility: Role of vascular nitric oxide. Endocrinology 137:1798-1803, 1996
23. Dominguez LJ, Peuler JD, Sowers JR: Endocrine regulation of vascular smooth muscle intermediary metabolism, in Sowers JR (ed): Contemporary Endocrinology: Endocrinology of the Vasculature. Totowa, NJ, Humana, 1996, pp 325-339
24. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669, 1996
25. Sowers JR: Effects of insulin and IGF-1 on vascular smooth muscle glucose and cation metabolism. Diabetes 45:47-51, 1996
26. Adams GR, Dillon PF: Glucose dependence of sequential norepinephrine contractions of vascular smooth muscle. Blood Vessels 26:77-83, 1989
27. Zhang C, Paul RJ: Excitation-contraction coupling and relaxation in porcine carotid arteries are specifically dependent on glucose. Am J Physiol 267:H1996-H2004, 1994
28. 2+ store in vascular smooth muscle. Blood Vessels 21:43-52, 1984
29. Peuler JD, Johnson BA, Phare SM, et al: Sex-specific effects of an insulin secretagogue in stroke-prone hypertensive rats. Hypertension 22:214-220, 1993
30. Kotchen TA, Zhang HY, Reddy S, et al: Effect of pioglitazone on vascular reactivity in vivo and in vitro. Am J Physiol 270:R660-R666, 1996
31. + channels in vasodilation induced by nitroglycerin, acetylcholine and nitric oxide. J Pharmacol Exp Ther 267:1327-1335, 1993
32. Lundholm L, Mohme-Lundholm E: Dissociation of contraction and stimulation of lactic acid production in experiments on smooth muscle under anaerobic conditions. Acta Physiol Scand 57:111-124, 1963
33. Buchanan TA, Meehan WP, Jeng YY, et al: Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J Clin Invest 96:354-360, 1995
34. Clapp LH, Gurney AM: Modulation of calcium movements by nitroprusside in isolated vascular smooth muscle cells. Pflugers Arch 418:462-470, 1991
35. 2+ sensitivity and partially by repolarization. Am J Physiol 271:H962-H968, 1996
36. i and uncoupling stress from myosin phosphorylation. Am J Physiol 263:C461-C467, 1992